Katherine A High

CIK 1631248 · See Remarks · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.63M

Companies

3

Total Filings

45

Lifetime Open-Market Net

-$12.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INCY Director 14,983 $108.53 $1.63M $0 8 2026-06-10
CRSP Director $49.80 $0 8 2026-06-09
Spark Therapeutics, Inc. (ONCE) Delisted See Remarks 700 -$12.80M 29 2019-12-17

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-14 CRSP Grant (A) $0 EDGAR
2021-05-28 INCY Grant (A) +1,923 $0 EDGAR
2020-06-15 CRSP Grant (A) $0 EDGAR
2020-05-28 INCY Grant (A) +1,282 $0 EDGAR
2020-03-30 INCY Grant (A) +139 $0 EDGAR
2019-12-17 Spark Therapeutics, Inc. (ONCE) Delisted Mixed −278,834 -$31.93M EDGAR
2019-06-13 CRSP Grant (A) $0 EDGAR
2019-03-25 Spark Therapeutics, Inc. (ONCE) Delisted Mixed +64,366 -$6.83M EDGAR
2019-01-23 Spark Therapeutics, Inc. (ONCE) Delisted Mixed +3,009 -$67.2K EDGAR
2019-01-17 Spark Therapeutics, Inc. (ONCE) Delisted Grant (A) $0 EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.